Report cover image

Controlled Substance Market

Publisher Coherent Market Insights
Published Aug 24, 2023
Length 175 Pages
SKU # CMI18163485

Description

Controlled Substance Market, By Drug type, By Application, By Distribution Channel, By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030


The global controlled substance market is a highly regulated and specialized sector within the pharmaceutical industry. Controlled substances are drugs that have the potential for abuse and dependence, and are therefore subject to strict government regulations. These substances are classified into different schedules based on their medical use, potential for abuse, and safety profile.

Market Dynamics:

The market dynamics of the global controlled substance market are influenced by various factors. The drivers of the market include the increasing prevalence of chronic diseases, rising demand for pain management drugs, and the growing geriatric population. On the other hand, the market is restrained by stringent government regulations, the risk of drug abuse and addiction, and the high cost of research and development.

However, the market also presents opportunities for growth. The development of novel drug delivery systems, advancements in technology, and the increasing focus on personalized medicine are expected to drive market growth. Additionally, the expansion of healthcare infrastructure in emerging economies and the growing awareness about mental health disorders are creating new avenues for market players.

In conclusion, the global controlled substance market is a highly regulated and specialized sector within the pharmaceutical industry. The market dynamics are influenced by various factors, including government regulations, market drivers, restraints, and opportunities. The key players in the market are focused on research, development, and distribution of controlled substances to meet the growing demand for pain management and chronic disease treatment.

Key features of the study:
  • This report provides in-depth analysis of the global controlled substance market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global controlled substance market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Johnson & Johnson, Pfizer, Sanofi, Merck & Co., Gilead Sciences, Amgen, Novartis, AbbVie, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Teva Pharmaceutical, Bayer, Novo Nordisk, Allergan, Takeda Pharmaceutical, Boehringer Ingelheim, Aspen Pharmacare, and Astellas Pharma. These companies are involved in the research, development, manufacturing, and distribution of controlled substances
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global controlled substance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global controlled substance market
Detailed Segmentation:
  • Global Controlled Substance Market, By Drug Type:
  • Opioids
  • Stimulants
  • Depressants
  • Hallucinogens
  • Anabolic Steroids
  • Global Controlled Substance Market, By Application:
  • Pain Management
  • Anxiety
  • Insomnia
  • Cough Suppression
  • ADHD
  • Narcolepsy
  • Global Controlled Substance Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Controlled Substance Market, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
  • Company Profiles:
  • Johnson & Johnson
  • Pfizer
  • Sanofi
  • Merck & Co.
  • Gilead Sciences
  • Amgen
  • Novartis
  • AbbVie
  • GlaxoSmithKline
  • AstraZeneca
  • Bristol-Myers Squibb
  • Eli Lilly
  • Teva Pharmaceutical
  • Bayer
  • Novo Nordisk
  • Allergan
  • Takeda Pharmaceutical
  • Boehringer Ingelheim
  • Aspen Pharmacare
  • Astellas Pharma

Table of Contents

175 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Drug Type
Market Snapshot, By Application
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Increasing prevalence of chronic diseases
Restraints
Stringent government regulations
Opportunities
Development of novel drug delivery systems
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Controlled Substance Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Controlled Substance Market , By Drug Type, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Opioids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Stimulants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Depressants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Hallucinogens
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Anabolic Steroids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
6. Global Controlled Substance Market , By Application, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018– 2030
Segment Trends
Pain Management
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Anxiety
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
InsoBnia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Cough Suppression
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
ADHD
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Narcolepsy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
7. Global Controlled Substance Market , By Distribution Channel, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018– 2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
8. Global Controlled Substance Market , By Region, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, By Country, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Country 2018–2030
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Middle East & Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
9. Competitive Landscape
Johnson & Johnson
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer
Sanofi
Merck & Co.
Gilead Sciences
Amgen
Novartis
AbbVie
GlaxoSmithKline
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva Pharmaceutical
Bayer
Novo Nordisk
Allergan
Takeda Pharmaceutical
Boehringer Ingelheim
Aspen Pharmacare
Astellas Pharma
Analyst Views
10. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on “Controlled Substance Market” - Global forecast to 2030

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us